Women's Health: An Investing Whitespace

Menopause, perimenopause, and hormone replacement therapy (HRT) are reshaping the conversation around women’s health and longevity. OB/GYN Dr. Stephanie Lam explains the science, symptoms, and why women’s healthcare may represent a major investing whitespace.PODCAST TEAMProducer & Director: Devon LeaverEditor: Dominique GuerraProduction Coordinator: Ying Yu LinProduction support: Annabelle ChanExecutive Editorial Advisor: Stephanie SirotaTheme music: Yehezkel RazAdditional music: APM MusicFeaturing: Dr. Stephanie Lam, OB/GYN, Carnegie Women’s Health, moderated by Stephanie Sirota, Partner, Chief Business Officer, RTW Investments, LP.FOLLOW USLove our podcast? Follow us on LinkedIn at RTW Investments, LP and check out our website for the latest updates and insights.To make sure you never miss an episode, you can subscribe to the RTW podcast on Spotify, Apple Podcasts, Amazon Music, and most other podcast platforms.CHAPTERS00:00 – Introduction00:55 - Dr. Lam’s Path to OB/GYN2:01 - Defining Menopause and Perimenopause5:05 - The Health Impact of HRT8:08 - A Holistic View of Women’s Health10:35 - GLPs and Women’s Healthcare14:25 - Investment Whitespaces in Women’s Health19:03 - OutroDISCLAIMERThis interview was given by Dr. Stephanie Lam, OB/GYN at Carnegie Women’s Health in New York, and moderated by Stephanie Sirota, Partner, Chief Business Officer at RTW Investments, LP. Statements reflect RTW's views and opinions as of the date hereof and not as of any future date. All expressions of opinion are subject to change without notice and are not intended to be a forecast of future events or results. The views expressed by guests are their own, and their appearance on the program does not imply an endorsement of them or any entity they represent.